Looking for patient voices to share thoughts on new way of delivering progesterone for miscarriage prevention
Looking for participants to shape a study on a new vaginal miscarriage prevention treatment
Link to organisation:
Full description:
Calla Lily Clinical Care is a UK-based women’s health company developing a new way to deliver vaginal progesterone – a hormone treatment used to help prevent miscarriage.
We are looking for women who have experience using vaginal progesterone (like Cyclogest) or who might be prescribed it in the future trying to get pregnant to join our patient engagement group.
Opportunity Deadline
1st September 2025
Payment:
£25 per hour
Expenses:
£5 per call
Organisation
Calla Lily Clinical Care
Calla Lily Clinical Care is an ambitious women’s health focused company that has developed the proprietary Callavid® platform for intravaginal drug delivery. Initial target indications are in fertility and pregnancy, where the company seeks to offer the world’s first drug-device combination product for both threatened miscarriage and IVF luteal phase support. NIHR i4i scheme is funding the first in human trial. Learn more about Calla Lily Clinical Care and the team at www.callali.ly
Details
Topic:
Reproductive health and pregnancy
Location:
UK wide
Involvement type:
All of research
What support is offered?
We will discuss support that might be needed and provide relevant support as required and that can be accommodated.
Can the work be done from home?
Yes
Suitable for a beginner?
Yes
